FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

British teen says urine, glue chucked at him while trying to carry on Charlie Kirk’s legacy in UK

Portion of Catholic students kidnapped in Nigeria escape as country grapples with anti-Christian violence

Scottish Lawmakers Refuse to Ban Shocking ‘Assisted Suicides’

Kennedy cousin tied to Martha Moxley case breaks silence 50 years later as murder remains unsolved

Former TV anchor heads to same prison as Ghislaine Maxwell after $63M COVID fraud conviction

Divine Judgment? Iran Experiencing Record Drought, Tehran Faces Evacuation

X’s new location feature exposes apparent fraudster accounts posing as Americans, Gaza journalists

‘Meta Never Told Parents…’: Court Docs Claim Meta Failed to Prevent Abuse of Minors

Trump’s wild Mamdani flip — the insults that came before the love fest

Climate Change Concern Plummets In Big Cities, Poll Finds

State Department Investigates Mass Migration as Potential Human Rights Violation

Vindman’s call to release Trump–MBS transcript reopens old questions in US–Saudi relationship

Michigan Senate Race Could Be GOP’s Best Midterms Offense Play: Poll

Heavily redacted voting records for school superintendent nabbed by ICE spark outrage

Trump trade official says $2K tariff payments won’t fuel inflation as revenues climb

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”